Evidence map›Paper›PMID 26472910›Full record

ArticleScience (New York, N.Y.)2015

Stable inhibitory activity of regulatory T cells requires the transcription factor Helios.

Hye-Jung Kim, R Anthony Barnitz, Taras Kreslavsky, Flavian D Brown, Howell Moffett, Madeleine E Lemieux, Yasemin Kaygusuz, Torsten Meissner, Tobias A W Holderried, Susan Chan and 3 more

Registry-linked trialAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06281262 (The Role of Selected Immunological Indicators and Microbiota in Patients Experiencing Premature Birth and Preeclampsia), which is not on this map. Cited by 287 papers.

0numbers the graph read from it
0cells of the map it votes in
287citing papers in PubMed
13.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06281262 unknown statusnot on this mapstarted 2023, after this paper: background citation

The Role of Selected Immunological Indicators and Microbiota in Patients Experiencing Premature Birth and Preeclampsia

TypeobservationalSponsorGeneral University Hospital, PragueRan2023 to 2025Enrolled100ConditionsPreterm Birth, PreeclampsiaArmsPeripheral blood collection, Swab sample collection
3 · Its place in the literature

Who cites it

287 citing papers in PubMed, 412 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. CD8+ Regulatory T Cells.Annual review of immunology · 2026
    Review
  18. Article
  19. Donor-derived CD8bioRxiv : the preprint server for biology · 2026
    Article
  20. Article

227 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Hye-Jung KimDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston MA.
R Anthony BarnitzDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Taras KreslavskyDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston MA.
Flavian D BrownDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Howell MoffettDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Madeleine E LemieuxBioinfo, Plantagenet, Canada.
Yasemin KaygusuzDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Torsten MeissnerDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston MA.
Tobias A W HolderriedDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston MA.
Susan ChanInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM U964, CNRS UMR 7104, Université de Strasbourg, 67404 Illkirch, France. Faculté de Médecine, Université de Strasbourg, Strasbourg, France.
Philippe KastnerInstitut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM U964, CNRS UMR 7104, Université de Strasbourg, 67404 Illkirch, France. Faculté de Médecine, Université de Strasbourg, Strasbourg, France.
W Nicholas HainingDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Pediatrics, Boston Children's Hospital, Boston, MA, USA. Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Harvey CantorDepartment of Cancer Immunology and Virology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Department of Microbiology and Immunobiology, Division of Immunology, Harvard Medical School, Boston MA. harvey_cantor@dfci.harvard.edu.
Dana-Farber Cancer Institute · USBoston Children's Hospital · USCentre National de la Recherche Scientifique · FR

Funding

IMMUNOLOGIC MECHANISMS THAT PREVENT AUTOIMMUNITYR01AI037562 · NIAID · DANA-FARBER CANCER INSTITUTE · PI CANTOR, HARVEY · 1996 to 2021
$9.4M
NIAID NIH HHS R01 AI037562NIAID NIH HHS R01AI37562
6 · The paper itself

Abstract

The maintenance of immune homeostasis requires regulatory T cells (T(regs)). Given their intrinsic self-reactivity, T(regs) must stably maintain a suppressive phenotype to avoid autoimmunity. We report that impaired expression of the transcription factor (TF) Helios by FoxP3(+) CD4 and Qa-1-restricted CD8 T(regs) results in defective regulatory activity and autoimmunity in mice. Helios-deficient T(regs) develop an unstable phenotype during inflammatory responses characterized by reduced FoxP3 expression and increased effector cytokine expression secondary to diminished activation of the STAT5 pathway. CD8 T(regs) also require Helios-dependent STAT5 activation for survival and to prevent terminal T cell differentiation. The definition of Helios as a key transcription factor that stabilizes T(regs) in the face of inflammatory responses provides a genetic explanation for a core property of T(regs).

Indexed as

AnimalsAutoimmunityCD8-Positive T-LymphocytesDNA-Binding ProteinsForkhead Transcription FactorsGene ExpressionKidneyLiverLymphocyte ActivationMiceMice, Inbred C57BLMice, TransgenicPancreasSTAT5 Transcription FactorT-Lymphocytes, RegulatoryTranscription FactorsDNA-Binding ProteinsForkhead Transcription FactorsFoxp3 protein, mouseSTAT5 Transcription FactorTranscription FactorsZfpn1a2 protein, mouse

Identifiers

PMID26472910
PMCPMC4627635
OpenAlexW2191493147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.